Global Hereditary Testing Market Segmentation, By Hereditary Cancer Testing (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Ovarian Cancer, Prostate Cancer, Stomach/Gastric Cancer, Melanoma, Sarcoma, Uterine Cancer, Pancreatic Cancer, Others), Hereditary Non-Cancer Testing (Genetic Tests, Newborn Genetic Screening, Preimplantation Genetic Diagnosis and Screening, Non-invasive Prenatal Testing (NIPT) and Carrier Screening Tests) – Industry Trends and Forecast to 2032
Hereditary Testing Market Analysis
The market for hereditary testing is predicted to expand significantly in the next years due to the rise in cancer and genetic illnesses, as well as increased knowledge and acceptance of personalized therapy. Pharmacogenomics, often known as drug-gene testing, has frequently used hereditary testing. Improvements in genetic testing methods are anticipated to accelerate market expansion.
Hereditary Testing Market Size
Global hereditary testing market size was valued at USD 2.47 billion in 2024 and is projected to reach USD 4.98 billion by 2032, with a CAGR of 9.15% during the forecast period of 2025 to 2032.
Report Scope and Market Segmentation
|
Attributes
|
Hereditary Testing Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Key Market Players
|
CENTOGENE N.V. (Germany), Ambry Genetics (U.S.), Myriad Genetics, Inc. (U.S.), NeoGenomics Laboratories (U.S.), Quest Diagnostics Incorporated (U.S.), PreventionGenetics (U.S.), Fulgent Genetics (U.S.), Invitae Corporation (U.S.), Medical Diagnostic Laboratories, L.L.C. (U.S.), Natera (U.S.), Caris Life Sciences (U.S.), LabSolutions (U.S.), Progenity Inc. (U.S.), ARUP Laboratories (U.S.)
|
|
Market Opportunities
|
|
Hereditary Testing Market Definition
In hereditary testing, particular inherited variations (variants) in a person's genes are changed. On the probability of contracting diseases, genetic variations might have negative, positive, neutral (no effect), or ambiguous effects. There is evidence that certain genes with harmful mutations enhance the likelihood of acquiring cancer. It is estimated that 5 to 10% of all malignancies are caused by these hereditary variations.
Hereditary Testing Market Dynamics
Drivers
- Increasing prevalence of hereditary cancer
Cancer is a genetic disorder produced due to definite changes in genes that administrate cell efficacy, mainly moving their growth and duplication. Hereditary genetic mutations are the reason of ~5–10% of all cancers. The detectives have related mutations in precise genes with added 50 hereditary cancer syndromes which effects entities in emerging certain cancers.
- Development in genomic technology
Breast cancer is one of the most collective cancers in the world affecting almost 12.5% of women during their lifetime and 5%–10% of these patients have a hereditary form. BRCA1 and BRCA2 genes are the two most mutual mutated genes, but additional genes connected with hereditary breast cancer are emerging. New developments in genomic skills have directed to parallel testing of multiple genes.
Opportunities
Mutation in the genes is one factor that impacts the early detection of hereditary cancer, increasing market growth. At the same time, efficacy and cost-effectiveness over traditional testing methods also drive market growth. Moreover, mounting demand for initial discovery and precise analysis is a feature that drives market growth.
Restraints/Challenges
The performance of hereditary multigene panel testing raises several issues, such as the measures that the patients have to meet to undertake the test and the patient’s clinical association, which will obstruct the market growth.
This hereditary testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hereditary testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Hereditary Testing Market Scope
The hereditary testing market is segmented on the basis of type, indication and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Multi Panel Test
- Single-site Genetic Test
Indication
- Breast Cancer
- Ovarian Cancer
- Colorectal Cancer
- Others
End-user
- Diagnostic Laboratory
- Hospitals
- Others
Hereditary Testing Market Regional Analysis
The hereditary testing market is analyzed and market size insights and trends are provided by country, type, indication and end user as referenced above.
The countries covered in the hereditary testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America, the market is dominates the market owing to rising throwaway revenue, availability of advanced healthcare infrastructure, and increasing adoption of genetic testing in the region.
Asia-Pacific and Europe are expected to a significant growth rate in the coming years due to growing cancer cases and developing healthcare sectors.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Hereditary Testing Market Share
The hereditary testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to hereditary testing market.
Hereditary Testing Market Leaders Operating in the Market Are:
- CENTOGENE N.V. ( Germany)
- Ambry Genetics (U.S.)
- Myriad Genetics, Inc. (U.S.)
- NeoGenomics Laboratories (U.S.)
- Quest Diagnostics Incorporated (U.S.)
- PreventionGenetics (U.S.)
- Fulgent Genetics (U.S.)
- Invitae Corporation (U.S.)
- Medical Diagnostic Laboratories, L.L.C. (U.S.)
- Natera (U.S.)
- Caris Life Sciences (U.S.)
- LabSolutions (U.S.)
- Progenity Inc. (U.S.)
- ARUP Laboratories (U.S.)
Latest Developments in Hereditary Testing Market
- In June 2020, Invitae and ArcherDX announced Monday morning that the two genetic testing companies have agreed to syndicate in command to expand their footmark in the cancer genetics and precision oncology space
SKU-